scholarly journals Acute paraoesophageal hiatal hernia following laparoscopic sleeve gastrectomy

2020 ◽  
Vol 7 (12) ◽  
pp. 4177
Author(s):  
Omar M. Alobaid ◽  
Abdullah S. Alzahrani ◽  
Bander I. Ali
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Hiatal Hernia ◽  
Independent Risk Factor ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Significant Weight Loss ◽  
Operative Endoscopy

Anti-obesity surgery is the most effective therapy available for significant weight loss in patients with morbid obesity. Obesity in consider a major independent risk factor for Hiatal hernia (HH) and it is present in about 37%-50% of morbidly obese patients undergoing bariatric surgery.1,2,3 It might be overlooked or under looked especially if the patient was asymptomatic and no pre-operative endoscopy or radiological workup. Denovo closure of the hiatal defect in case of an intraoperative finding of HH strongly recommended preventing such acute postoperative complications. Herein we report a rare and acute post laparoscopic sleeve gastrectomy with gastric herniation were uneventfully diagnosed and interfered early to prevent a catastrophic outcome.  

Efficiency of Cruroplasty as a Treatment of Gastro-Esophageal Reflux Disease in Morbid Obese Patients with Hiatus Hernia during SleeveGastrectomy

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Alaa Abbas Sabry ◽  
Youhanna Shohdy Shafik ◽  
Ahmed Mohamed Sabry ◽  
Andrew Nasr Faris Wanees
Keyword(s):  
Sleeve Gastrectomy ◽  
Hernia Repair ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Hiatal Hernia ◽  
Hiatus Hernia ◽  
Reflux Disease ◽  
Morbidly Obese ◽  
Hiatal Hernia Repair ◽  
Obese Patients ◽  
Gerd Symptoms

Abstract Background The effect of laparoscopic sleeve gastrectomy (LSG) on gastroesophageal reflux disease (GERD) is controversial. Although concomitant hiatal hernia repair (HHR) at the time of LSG is common and advocated by many, there are few data on the outcomes of GERD symptoms in these patients. The aim of this study was to evaluate the effect of concomitant HHR on GERD symptoms in morbidly obese patients undergoing LSG. Aim of the Work To analyse the impact of hiatal hernia repair (HHR) on gastro-oesophageal reflux disease (GERD) in morbidly obese patients with hiatus hernia undergoing laparoscopic sleeve gastrectomy (LSG). Patients and Methods This is a retrospective cohart study. We collected the data of Patients who underwent lap sleeve gastrectomy with cruroplsty in the same operation in the period between July 2018 and July 2019. Results Before surgery, symptomatic GERD was present in 14 patients (70%), and HH was diagnosed In 20 patients (100%), HH was diagnosed pre-operatively. The mean follow-up was 6 months. GERD remission occurred in 18 patients (90%). In the remaining 2 patients, antireflux medications were diminished, with complete control of symptoms. HH recurrences developed in 1 patient (10%). "De novo" GERD symptoms developed in 22.9% of the patients undergoing SG alone compared with 0% of patients undergoing SG plus HHR. Conclusion SG with HHR is feasible and safe, providing good management of GERD in obese patients with reflux symptoms. Small hiatal defects could be underdiagnosed at preoperative endoscopy and/or upper gastrointestinal contrast study. Thus, a careful examination of the crura is always recommended intraoperatively.

scholarly journals A COMPARISON OF EFECTIVENESS, AND AN ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY AND ROUX-EN-Y GASTRIC BYPASS

2016 ◽  
Vol 60 (2) ◽  
Author(s):  
Krzysztof Kaseja ◽  
Włodzimierz D. Majewski ◽  
Beata Kołpiewicz
Keyword(s):  
Quality Of Life ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Life Assessment ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Independent Observer ◽  
Minimal Invasiveness

Introduction: Morbid obesity is nowadays one of the major problems of well developed countries. Treatment of this disease comprises many modalities, but the most successful are surgical ones. With the advent of laparoscopic operations it became clear that these are particularly useful for operation in obese patients due to their minimal invasiveness. The aim of the study was to compare the effectiveness and quality of life of patients operated on for morbid obesity by laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux­‍‑en­‍‑Y gastric by­‍‑pass (LRYGB) by one surgeon in one surgical centre.Material and methods: Between 2006–2011 in the Department of General and Vascular Surgery, Szczecin‍‑Zdunowo Specialist Hospital, 74 morbidly obese patients (54 F, 20 M) were operated on by two methods. Mean age (42.4 and 45 years), and body mass index (46.5 ±8.9 kg/m2 for LSG and 45.1 ±4.4 kg/m2 for LRYGB) respectively, were comparable. One surgeon in one centre performed LSG in 33 patients (24 F, 9 M) and LRYGB in 41 patients (30 F, 11 M). An independent observer evaluated patients at times of up to 6 months (37 pts), and after 7 months to 36 months (37 pts) postoperatively. Quality of life was assessed by the Gastrointestinal Quality of Life Index (GIQLI) questionnaire, with accessory questions concerning sexual, physical and other activities before and after intervention.Results: There were no serious short or long term complications in either group of patients, although one patient in each group felt permanent postoperative discomfort (2.44% and 3.03%). Percentages of excess weight loss in both groups were similar and reached after 6 months 38.5% for LSG, 39.9% for LRYGB, and after 7–36 months 64.5% for LSG, 66.9% for LRYGB respectively. Quality of life assessment revealed significantly lower values in core symptoms for patients after LRYGB compared to LSG, but after LSG constipation was slightly more frequent. However, the general GIQLI score for patients after both types of surgery was statistically insignificant (110.6 for LSG versus 108.7 for LRYGB). In both groups sexual and physical activities significantly improved after operation.Conclusion: There were no significant differences in effectiveness and quality of life in patients after laparoscopic sleeve gastrectomy and laparoscopic Roux­‍‑en­‍‑Y gastric by­‍‑pass.

The Impact of Laparoscopic Sleeve Gastrectomy on Serum Zinc or Copper and Body Composition

2017 ◽  
Vol 68 (11) ◽  
pp. 2628-2634
Author(s):  
Daniel Timofte ◽  
Lacramioara Ochiuz ◽  
Manuela Ursaru ◽  
Bogdan Ciuntu ◽  
Lidia Ionescu ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Body Composition ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Serum Zinc ◽  
Serum Copper ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Fat Tissue ◽  
The Impact

The aim of this study was to investigate the impact of bariatric surgery on body composition, serum zinc and serum copper levels in obese patients over a period of 12 months following laparoscopic sleeve gastrectomy. This could be important considering that this procedure has been proven to be an effective tool in achieving absolute weight loss and reducing fat tissue in morbidly obese population. Thus, our present results are confirming some important modifications behind the biochemistry of the bariatric surgery and the aforementioned impact of laparoscopic sleeve gastrectomy on serum zinc or copper and body composition.

Health-related quality of life in morbid obesity: the impact of laparoscopic sleeve gastrectomy

Open Medicine ◽  
2014 ◽  
Vol 9 (3) ◽  
pp. 374-381 ◽  
Author(s):  
Radka Bužgová ◽  
Marek Bužga ◽  
Pavol Holéczy
Keyword(s):  
Quality Of Life ◽  
Mental Health ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
World Health ◽  
Morbidly Obese ◽  
Obese Patients ◽  
The Impact

AbstractOur aim in this prospective study was to determine the impact of laparoscopic sleeve gastrectomy on the quality of life of patients with morbid obesity in comparison with population standards. The study evaluated 76 morbidly obese patients who underwent laparoscopic sleeve gastrectomy. The short version of the World Health Organization Quality of Life questionnaire (WHOQOL-BREF) was used to evaluate quality of life in the following four areas: physical health, mental health, social relations, and environment. Patients completed the questionnaire before their planned operation and again 3 and 6 months after surgery. Compared with the population standard, patients with morbid obesity had significantly lower quality of life scores in the physical and mental health domains, including on independent questions related to of overall health and quality of life (p<0.001). Women scored lower on indicators of mental health than men. Three and 6 months following surgery a significant trend of body mass index (BMI) reduction was seen, as well as increased quality of life in all indicated areas (p<0.001). Laparoscopic sleeve gastrectomy treatment in morbidly obese patients reduced BMI on a long-term basis, a change seen as early as 3 months after surgery. By 6 months after surgery, patients had the same quality of life scores as the reference population.

scholarly journals Efficacy of laparoscopic sleeve gastrectomy for patient with morbid obesity and type 1 diabetes mellitus: a case report

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Hidetaka Ichikawa ◽  
Hirofumi Imoto ◽  
Naoki Tanaka ◽  
Hiroaki Musha ◽  
Shojiro Sawada ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Body Weight ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Hba1c Level ◽  
Insulin Dose ◽  
Body Weight Loss

Abstract Background Bariatric surgery is effective for the treatment of patients with morbid obesity and type 2 diabetes mellitus (T2DM), for body weight loss and glycemic control. However, in Japan, there has been no previous report of the effectiveness bariatric surgery in a case of morbid obesity associated with acute onset type 1 diabetes mellitus (T1DM), in which pancreatic β-cells were destroyed and endogenous insulin was depleted. Case presentation A 36-year-old woman with morbid obesity and T1DM, diagnosed when she was 6 years, was admitted for bariatric surgery. At her first consultation, she had a body weight of 106.7 kg and a body mass index of 42.2 kg/m2. Her HbA1c level was 9.0%, with a required daily insulin dose of 75 units. She underwent laparoscopic sleeve gastrectomy. At 1 year after surgery, her body weight had decreased to 81.0 kg and her body mass index to 32.2 kg/m2. In addition, her daily required dose of insulin had decreased to 24 units, with an improvement in her HbA1c level to 7.7%. Conclusions Although further evidence needs to be accumulated, including long-term outcomes, laparoscopic sleeve gastrectomy may provide an effective treatment for patients with morbid obesity and T1DM for body weight loss, improvement in HbA1c level, and insulin dose reduction.

Gastric Stenosis After Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients

2013 ◽  
Vol 23 (9) ◽  
pp. 1481-1486 ◽  
Author(s):  
Ana María Burgos ◽  
Attila Csendes ◽  
Italo Braghetto
Keyword(s):  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Gastric Stenosis
Sign in / Sign up

Export Citation Format

Share Document